...
首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Protective effects of butanol fraction from Betula Platyphyla var. japonica on cartilage alterations in a rabbit collagenase-induced osteoarthritis.
【24h】

Protective effects of butanol fraction from Betula Platyphyla var. japonica on cartilage alterations in a rabbit collagenase-induced osteoarthritis.

机译:白桦的丁醇级分的保护作用。粳对家兔胶原酶诱导的骨关节炎软骨改变的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM OF THIS STUDY: Many cartilage protective agents have been developed from natural products, and they have resulted in the development of treatments for osteoarthritis. In this study, we determined the osteoarthritic efficacy and mechanism of butanol fraction from the bark of Betula platyphylla var. japonica (BFBP) in collagenase-induced rabbit model of osteoarthritis (CIA). MATERIALS AND METHODS: The right knees of rabbits were injected intra-articularly with collagenase, and rabbits were orally administrated with distilled water (vehicle), BFBP (50, 100 and 200 mg/kg) or celecoxib (100 mg/kg) once a day for 28 days after the initiation of the CIA. RESULTS: Oral administration of BFBP dose-dependently suppressed the stiffness and global histologic score. Proteoglycan intensity was considerably increased in a dose-dependent manner. As well, the mRNA expression of MMP-1, and MMP-3 was decreased. On the contrary, the level of TIMP-1 in the synovial fluids was significantly increased in the BFBP treated group. The pathologic inflammatory molecules such as PGE2 and COX-2 were inhibited by BFBP, but COX-1 expression not affected. CONCLUSION: We suggest that BFBP has shown the protective effect on cartilage alternations through balance of MMPs/TIMP-1 and regulates inflammatory-related molecules in vivo model of osteoarthritis, and great candidate for development of osteoarthritis treatment.
机译:这项研究的目的:许多软骨保护剂是从天然产物中开发出来的,它们导致了骨关节炎的治疗方法的发展。在这项研究中,我们确定了白桦树皮的丁醇级分的骨关节炎功效和机理。胶原酶诱导的兔骨关节炎(CIA)模型中的粳稻(BFBP)。材料与方法:兔右膝关节腔内注射胶原酶,每只兔口服一次蒸馏水(车辆),BFBP(50、100和200 mg / kg)或塞来昔布(100 mg / kg)口服。中央情报局启动后的28天。结果:口服BFBP剂量依赖性地抑制了僵硬和整体组织学评分。蛋白聚糖强度以剂量依赖性方式显着增加。同样,MMP-1和MMP-3的mRNA表达下降。相反,在BFBP治疗组中,滑液中TIMP-1的水平显着增加。 BFBP可抑制PGE2和COX-2等病理性炎症分子,但COX-1的表达不受影响。结论:我们认为BFBP通过MMPs / TIMP-1的平衡显示出对软骨交变的保护作用,并在骨关节炎体内模型中调节炎症相关分子,是发展骨关节炎治疗的极佳候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号